J. Sanz, P. Moreno, and V. Fuster, The Year in Atherothrombosis, Journal of the American College of Cardiology, vol.62, issue.13, pp.1131-1143, 2013.
DOI : 10.1016/j.jacc.2013.06.045

P. Libby, M. Dicarli, and R. Weissleder, The Vascular Biology of Atherosclerosis and Imaging Targets, Journal of Nuclear Medicine, vol.51, issue.Supplement_1, pp.33-37, 2010.
DOI : 10.2967/jnumed.109.069633

J. Berman, M. Farkouh, and R. Rosenson, Emerging anti-inflammatory drugs for atherosclerosis, Expert Opinion on Emerging Drugs, vol.5, issue.2, pp.193-205, 2013.
DOI : 10.2174/187152908786786188

V. Fuster, P. Moreno, Z. Fayad, R. Corti, and J. Badimon, Atherothrombosis and High-Risk Plaque, Journal of the American College of Cardiology, vol.46, issue.6, pp.937-954, 2005.
DOI : 10.1016/j.jacc.2005.03.074

O. Brien, K. Mcdonald, T. Chait, A. Allen, M. Alpers et al., Neovascular Expression of E-Selectin, Intercellular Adhesion Molecule-1, and Vascular Cell Adhesion Molecule-1 in Human Atherosclerosis and Their Relation to Intimal Leukocyte Content, Circulation, vol.93, issue.4, pp.672-682, 1996.
DOI : 10.1161/01.CIR.93.4.672

O. Brien, K. Allen, M. Mcdonald, and T. , Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis., Journal of Clinical Investigation, vol.92, issue.2, pp.945-951, 1993.
DOI : 10.1172/JCI116670

M. Davies, J. Gordon, and A. Gearing, The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis, The Journal of Pathology, vol.187, issue.3, pp.223-229, 1993.
DOI : 10.1002/path.1711710311

M. Naghavi, P. Libby, and E. Falk, From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II, Circulation, vol.108, issue.15, pp.1772-1778, 2003.
DOI : 10.1161/01.CIR.0000087481.55887.C9

C. Xavier, I. Vaneycken, D. Huyvetter, and M. , Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer, Journal of Nuclear Medicine, vol.54, issue.5, pp.776-784, 2013.
DOI : 10.2967/jnumed.112.111021

A. Broisat, S. Hernot, and J. Toczek, Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions, Circulation Research, vol.110, issue.7, pp.927-937, 2012.
DOI : 10.1161/CIRCRESAHA.112.265140
URL : https://hal.archives-ouvertes.fr/inserm-00831749

P. Barter and K. Rye, Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk, The Journal of Lipid Research, vol.53, issue.9, pp.1755-1766, 2012.
DOI : 10.1194/jlr.R024075

M. Elkhawad, J. Rudd, and L. Sarov-blat, Effects of p38 Mitogen-Activated Protein Kinase Inhibition on Vascular and Systemic Inflammation in Patients With Atherosclerosis, JACC: Cardiovascular Imaging, vol.5, issue.9
DOI : 10.1016/j.jcmg.2012.02.016

B. Everett, A. Pradhan, and D. Solomon, Rationale and design of the Cardiovascular Inflammation Reduction Trial: A test of the inflammatory hypothesis of atherothrombosis, American Heart Journal, vol.166, issue.2, pp.199-207, 2013.
DOI : 10.1016/j.ahj.2013.03.018

P. Ridker, T. Thuren, A. Zalewski, and P. Libby, Interleukin-1?? inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS), American Heart Journal, vol.162, issue.4, pp.597-605, 2011.
DOI : 10.1016/j.ahj.2011.06.012

I. Bot, J. Jukema, I. Lankhuizen, T. Van-berkel, and E. Biessen, Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels, Atherosclerosis, vol.214, issue.2, pp.295-300, 2011.
DOI : 10.1016/j.atherosclerosis.2010.11.008

M. Nahrendorf, F. Jaffer, and K. Kelly, Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis, Circulation, vol.114, issue.14, pp.1504-1511, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.646380

A. Brautbar and C. Ballantyne, Pharmacological strategies for lowering LDL cholesterol: statins and beyond, Nature Reviews Cardiology, vol.106, issue.5, pp.253-265, 2011.
DOI : 10.1038/nrcardio.2011.2

L. Rasmussen, P. Hansen, M. Nabipour, P. Olesen, M. Kristiansen et al., Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells, Biochemical Journal, vol.360, issue.2, pp.363-370, 2001.
DOI : 10.1042/bj3600363

P. Ridker, E. Danielson, and F. Fonseca, Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein, New England Journal of Medicine, vol.359, issue.21, pp.2195-2207, 2008.
DOI : 10.1056/NEJMoa0807646

C. Grothusen, S. Bley, and S. T. , Combined effects of HMG-CoA-reductase inhibition and renin???angiotensin system blockade on experimental atherosclerosis, Atherosclerosis, vol.182, issue.1
DOI : 10.1016/j.atherosclerosis.2005.01.045

Y. Nakashima, A. Plump, E. Raines, J. Breslow, and R. Ross, ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.14, issue.1
DOI : 10.1161/01.ATV.14.1.133

M. Nahrendorf, E. Keliher, and P. Panizzi, 18F-4V for PET???CT Imaging of VCAM-1 Expression in Atherosclerosis, JACC: Cardiovascular Imaging, vol.2, issue.10, pp.1213-1222, 2009.
DOI : 10.1016/j.jcmg.2009.04.016

P. Nachtigal, N. Pospisilova, and G. Jamborova, Atorvastatin has hypolipidemic and antiinflammatory effects in apoE/LDL receptor-double-knockout mice, Life Sci, vol.82, pp.13-14708, 2008.

N. Haider, D. Hartung, and S. Fujimoto, Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis, Journal of Nuclear Cardiology, vol.350, issue.5, pp.753-762, 2009.
DOI : 10.1007/s12350-009-9107-8

M. Ogawa, Y. Magata, and T. Kato, Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques, J Nucl Med, vol.47, pp.1845-1850, 2006.

E. Vucic, S. Dickson, and C. Calcagno, Pioglitazone Modulates Vascular Inflammation in Atherosclerotic Rabbits, JACC: Cardiovascular Imaging, vol.4, issue.10, pp.1100-1109, 2011.
DOI : 10.1016/j.jcmg.2011.04.020

E. Vucic, C. Calcagno, and S. Dickson, Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945, JACC: Cardiovascular Imaging, vol.5, issue.8, pp.819-828, 2012.
DOI : 10.1016/j.jcmg.2011.11.025

A. Tawakol, Z. Fayad, and R. Mogg, Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation, Journal of the American College of Cardiology, vol.62, issue.10, pp.909-917, 2013.
DOI : 10.1016/j.jacc.2013.04.066

C. Harisankar, B. Mittal, K. Agrawal, M. Abrar, and A. Bhattacharya, Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake, Journal of Nuclear Cardiology, vol.49, issue.5, pp.926-936, 2011.
DOI : 10.1007/s12350-011-9422-8

M. Sadeghi, D. Glover, G. Lanza, Z. Fayad, and L. Johnson, Imaging Atherosclerosis and Vulnerable Plaque, Journal of Nuclear Medicine, vol.51, issue.Supplement_1, pp.51-65, 2010.
DOI : 10.2967/jnumed.109.068163
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911776